Areas of Expertise

Huang Jiuzuo is an Associate Chief Physician and MD at the Department of Plastic and Aesthetic Surgery, Peking Union Medical College Hospital. He specializes in customized double eyelid surgery, double eyelid revision, various ocular plastic surgeries, minimally invasive injectable cosmetic treatments, facial autologous fat grafting, and facial rejuvenation.

Biography

Huang Jiuzuo, Associate Chief Physician, MD, is Deputy Director of the Department of Plastic and Aesthetic Surgery, Peking Union Medical College Hospital. In 2001, he entered the premedical program at Tsinghua University. In 2009, he graduated from the eight-year clinical medicine program at Peking Union Medical College and was awarded a Doctor of Medicine degree. He previously served as a surgical resident, chief resident, and attending physician at Peking Union Medical College Hospital. In July 2019, he obtained the professional technical qualification certificate as Associate Chief Physician in Plastic Surgery from the National Health Commission. In September 2020, he was appointed Associate Chief Physician at Peking Union Medical College Hospital. He has studied at Massachusetts General Hospital and Brigham and Women's Hospital, affiliated with Harvard Medical School. He strives to achieve the best aesthetic results with minimal trauma and to perform reconstructive work according to aesthetic standards.

Areas of expertise:
In aesthetic surgery, he specializes in customized double-eyelid surgery, double-eyelid revision surgery, various oculoplastic procedures (transconjunctival lower blepharoplasty, transcutaneous lower blepharoplasty, ptosis, divided nevus of the eyelid, etc.), minimally invasive injectable aesthetic treatments (jawline slimming injections, wrinkle-reducing injections, botulinum toxin, hyaluronic acid), autologous facial fat grafting, and facial rejuvenation (upper eyelid skin laxity, brow lift, tear trough correction, etc.).

In reconstructive surgery, he specializes in the surgical treatment and reconstruction of skin and soft tissue tumors (such as malignant melanoma, dermatofibrosarcoma protuberans, cutaneous squamous cell carcinoma, and basal cell carcinoma).

Scar revision (comprehensive treatment with surgery, laser, and medication), superficial body masses (pigmented nevi, sebaceous cysts, lipomas, etc.), skin and soft tissue tumors (cutaneous squamous cell carcinoma, basal cell carcinoma, malignant melanoma, dermatofibrosarcoma protuberans, etc.), and injectable treatment for hyperhidrosis and bromhidrosis (such as axillary osmidrosis and perineal bromhidrosis).

Society Memberships:
Deputy Group Leader, Ocular Aesthetic Group, Plastic Surgery Branch, Chinese Medical Association
Member, Plastic Surgery Branch, Chinese Research Hospital Association
Member, Youth Committee, Anti-Aging Branch, Chinese Association of Plastic and Aesthetic Surgery
and Council Member, Medical Aesthetics and Art Branch Council, Chinese Association of Plastic and Aesthetic Surgery